NEJM Interview: Interview with Professor Kevin Outterson on the FDA’s guidance on off-label promotion and the move toward clinical trial transparency. - a podcast by The New England Journal of Medicine

Kevin Outterson is a professor of health law, bioethics, and human rights at the Boston University School of Law. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. K. Outterson. Clinical Trial Transparency - Antidote to Weaker Off-Label-Promotion Rules? N Engl J Med 2014;371:1-3.

Further episodes of 301 Moved Permanently

Further podcasts by The New England Journal of Medicine

Website of The New England Journal of Medicine